The Supreme Court of the United States (SCOTUS) faces a complex issue as Purdue Pharma, the manufacturer of OxyContin, seeks bankruptcy protection. Simultaneously, the country is witnessing Roundup trials take different paths across the states. Law.com analyses these current legal disputes.
Purdue Pharma’s bankruptcy case has started showing fault lines within the SCOTUS, challenging its united front on bankruptcy law. Although information regarding the specifics of the disagreement is scarce at the moment, there is a clear sign of a deviating stand within the apex court’s ranks.
Parallelly, the legal saga involving Roundup, a weedkiller linked to non-Hodgkin’s lymphoma, finds itself at crossroads. One trial is winding up while another one looms on the horizon. These trials mark the next phase in the extensive multistate litigation brought against Monsanto, now owned by Bayer.
From precedent-setting bankruptcy hearings to large-scale product liability disputes, these cases underscore the rapidly evolving landscape of litigation in America’s corporate law sector.